Consistent with ARAF-amplified SCLC-transformed cases, SCLC transformation predominantly occurs in tumors with EGFR exon 19 deletion, with transformed tumors maintaining their founder mutations [4,22]. Here, ARAF is linked to small cell lung carcinoma.